37 results
8-K
EX-99.1
ABSI
Absci Corp
14 May 24
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
7:32am
internal therapeutic asset programs, including our clinical development strategy, the progress, milestones and success of our internal asset programs
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
and drug creation programs with third parties. * Table of Contents 12
Strategy We believe we represent a new breed of biotechnology company, integrating … discovery. Our Growth Strategy Our goal is to establish our proprietary, end-to-end platform as the industry standard for biologic drug creation. Our growth
424B5
ko6g oa382rf84ej
28 Feb 24
Prospectus supplement for primary offering
8:34am
8-K
0sj85cu
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
gjgrbxxv83i4hck580
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
rx0kjhnisf4m o5t2
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
ftjzwuw4sgfgoxmmks1
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
EX-99.1
3oqyk8ve
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
ARS
95bzd8 utwhfi2u6
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
6wpxph54aulby
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
n9l24
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm